Sheng Guo
YOU?
Author Swipe
View article: High-salt diet promote colorectal cancer progression by inhibiting necroptosis via SGK1
High-salt diet promote colorectal cancer progression by inhibiting necroptosis via SGK1 Open
Introduction: The purpose of this study was to explore the potential mechanism of high salt diet on the progression of colorectal cancer.Methods: Colorectal cancer cells Caco-2 and HT-29 were treated with varying concentrations of sodium c…
View article: Let-7i-3p inhibits the progression of gastric cancer by targeting CCND1 and suppressing the NF-κB signaling pathway
Let-7i-3p inhibits the progression of gastric cancer by targeting CCND1 and suppressing the NF-κB signaling pathway Open
Gastric cancer (GC) often presents as a malignant tumor of the human digestive system. Let-7i-3p has been confirmed to participate in the regulation of various cancers, while the biological mechanisms of Let-7i-3p in GC remains unknown. In…
View article: Spatial and temporal distribution of Neolithic settlement sites along the Hanjiang River corridor in southern Shaanxi and their driving factors
Spatial and temporal distribution of Neolithic settlement sites along the Hanjiang River corridor in southern Shaanxi and their driving factors Open
The Southern Shaanxi Hanjiang Corridor is a vital area for prehistoric human activities, one of the origins of Chinese civilization, and a crucial cultural exchange route. Based on GIS(Geographic Information System) spatial analysis method…
View article: Ginsenoside Rg1 exerts anti-arrhythmic effect by inhibiting I <sub>CaL</sub> through cAMP-PKA and PI3K-AKT signaling pathways in rat ventricular myocytes after myocardial ischemia-reperfusion injury
Ginsenoside Rg1 exerts anti-arrhythmic effect by inhibiting I <sub>CaL</sub> through cAMP-PKA and PI3K-AKT signaling pathways in rat ventricular myocytes after myocardial ischemia-reperfusion injury Open
Objective Ginsenoside Rg1 has demonstrated beneficial effects in myocardial ischemia-reperfusion (I/R) injury. However, its potential anti-arrhythmic role in ventricular arrhythmias remains unclear. Methods In this study, a whole-cell patc…
View article: Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma
Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma Open
Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resistance. Pre…
View article: Intestinal flora and linear growth in children
Intestinal flora and linear growth in children Open
The gut microbiota plays a critical role in human growth and development as well as the regulation of human pathophysiological processes. According to research, the gut microbiota controls the host's growth and development in areas such as…
View article: Application of tumor microparticles in tumor prevention and treatment
Application of tumor microparticles in tumor prevention and treatment Open
Tumor microparticles (T-MPs) are vesicles released from tumor cells when they receive apoptotic or stimuli signals. T-MPs, which contain some proteins, lipids and nucleic acids from tumor cells, contribute to the exchange of material, ener…
View article: Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma
Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma Open
Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resistance. Pre…
View article: Reviewer #2 (Public Review): Nifuroxazide enhances radiotherapy efficacy against hepatocellular carcinoma by upregulating PD-L1 degradation via the ubiquitin-proteasome pathway
Reviewer #2 (Public Review): Nifuroxazide enhances radiotherapy efficacy against hepatocellular carcinoma by upregulating PD-L1 degradation via the ubiquitin-proteasome pathway Open
Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resistance. Pre…
View article: Reviewer #3 (Public Review): Nifuroxazide enhances radiotherapy efficacy against hepatocellular carcinoma by upregulating PD-L1 degradation via the ubiquitin-proteasome pathway
Reviewer #3 (Public Review): Nifuroxazide enhances radiotherapy efficacy against hepatocellular carcinoma by upregulating PD-L1 degradation via the ubiquitin-proteasome pathway Open
Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resistance. Pre…
View article: Nifuroxazide enhances radiotherapy efficacy against hepatocellular carcinoma by upregulating PD-L1 degradation via the ubiquitin-proteasome pathway
Nifuroxazide enhances radiotherapy efficacy against hepatocellular carcinoma by upregulating PD-L1 degradation via the ubiquitin-proteasome pathway Open
Background Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resi…
View article: Reviewer #1 (Public Review): Nifuroxazide enhances radiotherapy efficacy against hepatocellular carcinoma by upregulating PD-L1 degradation via the ubiquitin-proteasome pathway
Reviewer #1 (Public Review): Nifuroxazide enhances radiotherapy efficacy against hepatocellular carcinoma by upregulating PD-L1 degradation via the ubiquitin-proteasome pathway Open
Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resistance. Pre…
View article: Nifuroxazide Suppresses PD-L1 Expression and Enhances the Efficacy of Radiotherapy in Hepatocellular Carcinoma
Nifuroxazide Suppresses PD-L1 Expression and Enhances the Efficacy of Radiotherapy in Hepatocellular Carcinoma Open
Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resistance. Pre…
View article: Molecular pathology and clinical treatment of independent <scp>HPV</scp> primary serous carcinoma of the uterine cervix (USCC): A case report
Molecular pathology and clinical treatment of independent <span>HPV</span> primary serous carcinoma of the uterine cervix (USCC): A case report Open
On October 23, 2020, a 69‐year‐old Chinese female patient was admitted to Yuncheng Hospital due to a history of postmenopausal bleeding and lower abdominal pain for 5 months. The HPV test and pathology results indicated the presence of ind…
View article: Editorial: Innovators in structural materials—alloys and metals
Editorial: Innovators in structural materials—alloys and metals Open
EDITORIAL article Front. Mater., 23 August 2023Sec. Structural Materials Volume 10 - 2023 | https://doi.org/10.3389/fmats.2023.1279017
View article: Figure S1 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines
Figure S1 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Open
Figure S1. Comparison of gene expression within and between cancer types when the number of pairwise DEGs is 3000.
View article: Figure S2 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines
Figure S2 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Open
Figure S2. The relationship between number of unique genes and number of pairwise DEGs in the TCGA dataset.
View article: Figure S2 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines
Figure S2 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Open
Figure S2. The relationship between number of unique genes and number of pairwise DEGs in the TCGA dataset.
View article: Figure S1 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines
Figure S1 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Open
Figure S1. Comparison of gene expression within and between cancer types when the number of pairwise DEGs is 3000.
View article: Supplemental Figure Legends from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines
Supplemental Figure Legends from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Open
Supplemental Figure Legends
View article: Supplemental Figure Legends from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines
Supplemental Figure Legends from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Open
Supplemental Figure Legends
View article: Figure S3 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines
Figure S3 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Open
Figure S3. Immunohistochemistry (IHC) staining for confirmation of tumor types.
View article: Supplemental Table S2 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines
Supplemental Table S2 from Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Open
PDX list